Natural supplement may shield hearts from chemo damage
NCT ID NCT06703593
Summary
This study tested whether alpha lipoic acid, a natural antioxidant supplement, could protect the heart from damage caused by the chemotherapy drug doxorubicin in breast cancer patients. Researchers enrolled 80 Egyptian women with breast cancer who were starting doxorubicin treatment to see if taking alpha lipoic acid could help maintain heart function and reduce heart-related side effects. The study measured heart function through echocardiograms and blood tests to determine if the supplement provided meaningful protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER - FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The British University in Egypt
Cairo, El-Sherouk City, 11837, Egypt
Conditions
Explore the condition pages connected to this study.